Stevens Professor Develops First Deep Learning Model to Predict High Concentration Antibody Viscosity

Monoclonal antibody therapeutics are complicated to develop, complicated to manufacture and complicated to administer. Beneficial in the treatment of a variety of diseases and conditions — including cancer,